| Literature DB >> 30505249 |
Xueyong Zuo1,2, Qiu Chen1,3, Houwen Li4, Ke Zhang1,3, Kongzhao Wang4, Yu Tu1,3, Mingjiang Hu1,3, Fengmei Cui1,3, Yulong Liu1,3,5.
Abstract
The purpose of this study was to investigate the effects of Chahuangjing, a novel traditional Chinese medicinal compound, on decorporation and radiation protection against tritiated water (HTO). Sixty male specific-pathogen-free-grade C57BL/6J mice were randomly divided into 12 groups: mice in 4 control groups were intraperitoneally injected with sterile water; mice in 4 HTO groups were intraperitoneally injected with 11.1 × 105 Bq/g of HTO; and mice in the other 4 groups were administered with HTO and a Chahuangjing compound (0.2 mL, once daily). After 1, 7, 14, and 21 days, the mice were killed and samples were collected. A liquid scintillation counting method was used for tritium measurement. A fully automated hematology analyzer was used to assess blood samples. The superoxide dismutase (SOD) and malondialdehyde (MDA) content was analyzed using commercial kits. Chahuangjing significantly increased decorporation and shortened the effective half-life of tritium. To a certain extent, Chahuangjing alleviated the HTO-induced reduction in white blood cells and elevated red blood cells after HTO exposure. Moreover, Chahuangjing alleviated the HTO-induced reduction in SOD activity and reduced MDA. Our study demonstrated that Chahuangjing can enhance the elimination of tritium and reduce free radicals to alleviate HTO-induced radiation injury.Entities:
Keywords: Chahuangjing; decorporation; radiation protection; tritiated water
Year: 2018 PMID: 30505249 PMCID: PMC6256306 DOI: 10.1177/1559325818810650
Source DB: PubMed Journal: Dose Response ISSN: 1559-3258 Impact factor: 2.658
Tritium Quantity in the Liver Tissue of Mice.
| Time (Days) | Number | Control Group | HTO Group | Chahuangjing Group |
|---|---|---|---|---|
| 1 | 5 | 3711.72 ± 304.26a | 10 400 991.7 ± 4 650 760.88b | 9 727 025.91 ± 2 116 559.25b |
| 7 | 5 | 4421.27 ± 1243.38a | 3 477 780.16 ± 2 081 339.71b | 2 367 244.94 ± 1 446 494.70b |
| 14 | 5 | 4395.85 ± 1083.18a | 913 025.74 ± 494 369.11b | 386 329.03 ± 93539.04b,a |
| 21 | 5 | 3960.68 ± 354.73 | 117 721.27 ± 59858.83 | 51351.03 ± 12 699.68b,a |
Abbreviation: HTO, tritiated water.
a Compared to HTO group at the same time point, P < .05.
b Compared to control group at the same time point, P < .05.
Data Before HTO Exposure, Fitting Value Deviation, and Actual Measured Value Deviation.
| Time (Days) | HTO Group | Standard Deviation | Fitting Value Deviation (21 Days) | Fitting Value Deviation (14 Days) | Chahuangjing Group | Standard Deviation | Fitting Value Deviation (21 Days) | Fitting Value Deviation (14 Days) |
|---|---|---|---|---|---|---|---|---|
| 1 | 1.04E + 07 | 4.65E + 06 | 12.77% | 0.60% | 9.73E + 06 | 2.12E + 06 | 5.09% | 0.50% |
| 7 | 3.48E + 06 | 2.08E + 06 | −10.45% | −2.27% | 2.37E + 06 | 1.45E + 06 | −11.42% | −7.30% |
| 14 | 9.13E + 05 | 4.94E + 05 | −27.38% | 0.27% | 3.86E + 05 | 9.35E + 04 | −14.48% | −0.60% |
| 21 | 1.18E + 05 | 5.99E + 04 | 19.90% | 5.14E + 04 | 1.27E + 04 | 1.37% |
Abbreviation: HTO, tritiated water.
Estimated Parameter Values.
| 14 Days | 21 Days | |||||
|---|---|---|---|---|---|---|
| Fitting parameters |
|
|
|
|
|
|
| HTO group | 0.1874 ± 0.054 | 3.699 (2.87, 5.19) | 1.262E + 07 | 0.2214 ± 0.032 | 3.130 (2.73, 3.67) | 1.463E + 07 |
| Chahuangjing group | 0.2490 ± 0.025 | 2.783 (2.53, 3.09) | 1.254E + 07 | 0.2637 ± 0.016 | 2.6285 (2.48, 2.80) | 1.331E + 07 |
Abbreviation: HTO, tritiated water.
Peripheral White Blood Cell Counting (×109/L).
| Time (Days) | Control Group | HTO Group | Chahuangjing Group |
|---|---|---|---|
| 1 | 3.72 ± 2.12 | 4.09 ± 1.43 | 2.77 ± 2.10 |
| 7 | 4.38 ± 1.60 | 3.23 ± 1.03a | 6.18 ± 1.56b |
| 14 | 3.55 ± 0.68 | 2.40 ± 0.37a | 4.74 ± 1.47b |
| 21 | 6.73 ± 0.70 | 6.83 ± 0.88 | 8.76 ± 3.17 |
Abbreviation: HTO, tritiated water.
a Compared to control group at the same time point, P < .05.
b Compared to HTO group at the same time point, P < .05.
Peripheral Lymphocyte Number Counting (×109/L).
| Time (Days) | Control Group | HTO Group | Chahuangjing Group |
|---|---|---|---|
| 1 | 2.94 ± 2.18 | 3.29 ± 1.29 | 1.88 ± 2.08 |
| 7 | 1.85 ± 1.53 | 5.31 ± 1.03a | 5.17 ± 1.61a |
| 14 | 2.74 ± 0.40 | 1.70 ± 0.49 | 1.61 ± 1.43 |
| 21 | 5.75 ± 0.64 | 5.88 ± 0.68 | 7.18 ± 2.53 |
Abbreviation: HTO, tritiated water.
a Compared to control group at the same time point, P < .05.
Peripheral Neutrophil Counting (×109/L).
| Time (Days) | Control Group | HTO Group | Chahuangjing Group |
|---|---|---|---|
| 1 | 0.52 ± 0.15 | 0.62 ± 0.21 | 0.74 ± 0.36 |
| 7 | 1.45 ± 0.45 | 0.89 ± 1.72 | 0.90 ± 0.15 |
| 14 | 0.63 ± 0.05 | 0.64 ± 0.03 | 0.78 ± 0.08 |
| 21 | 0.82 ± 0.11 | 0.79 ± 0.17 | 1.36 ± 0.69 |
Abbreviation: HTO, tritiated water.
Peripheral Red Blood Cell Counting (×1012/L).
| Time (Days) | Control Group | HTO Group | Chahuangjing Group |
|---|---|---|---|
| 1 | 9.57 ± 0.44 | 9.30 ± 0.41 | 10.32 ± 0.25 |
| 7 | 9.64 ± 0.25 | 9.48 ± 0.35 | 10.20 ± 0.10 |
| 14 | 9.98 ± 0.19a | 9.03 ± 0.05b | 10.31 ± 0.12a |
| 21 | 9.66 ± 0.56 | 10.06 ± 0.46 | 10.60 ± 0.42 |
Abbreviation: HTO, tritiated water.
a Compared to HTO group at the same time point, P < .05.
b Compared to control group at the same time point, P < .05.
Peripheral Platelet Count (×109/L).
| Time (Days) | Control Group | HTO Group | Chahuangjing Group |
|---|---|---|---|
| 1 | 959.60 ± 154.78 | 1035.60 ± 293.13 | 1113.60 ± 217.91 |
| 7 | 850.00 ± 48.01 | 814.33 ± 23.18 | 744.33 ± 118.81 |
| 14 | 969.17 ± 99.55 | 856.17 ± 62.71 | 883.17 ± 78.94 |
| 21 | 765.50 ± 95.47 | 621.20 ± 156.09 | 754.00 ± 149.90 |
Abbreviation: HTO, tritiated water.
Hepatic SOD Activity (U/mg protein).
| Time (Days) | Control Group | HTO Group | Chahuangjing Group |
|---|---|---|---|
| 1 | 225.27 ± 30.38 | 189.36 ± 43.84 | 253.95 ± 95.53 |
| 7 | 129.54 ± 63.34 | 56.72 ± 9.36a | 121.16 ± 54.97b |
| 14 | 167.17 ± 91.49 | 107.82 ± 31.26a | 132.61 ± 83.75 |
| 21 | 159.08 ± 48.73 | 104.99 ± 27.59a | 163.47 ± 52.89b |
Abbreviations: HTO, tritiated water; SOD, superoxide dismutase.
a Compared to control group at the same time point, P < .05.
b Compared to HTO group at the same time point, P < .05.
Hepatic MDA Content (nmol/mg protein).
| Time (Days) | Control Group | HTO Group | Chahuangjing Group |
|---|---|---|---|
| 1 | 4.71 ± 1.75 | 7.19 ± 2.51 | 5.95 ± 1.30 |
| 7 | 2.56 ± 1.77 | 2.14 ± 1.17 | 2.45 ± 1.24 |
| 14 | 3.46 ± 2.09 | 4.65 ± 1.06 | 2.37 ± 0.39a |
| 21 | 4.62 ± 1.46 | 9.61 ± 6.89b | 7.69 ± 3.55a |
Abbreviations: HTO, tritiated water; MDA, malondialdehyde.
a Compared to HTO group at the same time point, P < .05.
b Compared to control group at the same time point, P < .05.